Sodium Hyaluronate
Sodium Hyaluronate is a transparent, high viscosity sodium salt used in eye surgery to replace eye fluids (aqueous and vitreous humour).
Primary Characteristics
It is of origin and belongs to Hyaluronic Acid .
It is classified in Opthalmic Agemt. Viscoelastic pharmacological group.
Solubility in Water: null · Solubility in Alcohol: null · Non-proprietary name: Sodium Hyaluronate.
Pharmacokinetics
Distribution: Sodium Hyaluronate has a volume of distribution is . plasma protein binding is .
Elimination: it is metabolised via , plasma half-life is , renal excretion is .
Advertisement
Indications
Sodium Hyaluronate is primarily indicated in conditions like Aid in opthalmic surgery.
Contraindications
None recorded.
Dosage
Sodium Hyaluronate's dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 1 % | 1 % | — | Ophthalmic | Injection. |
| 4 mg | 4 mg | — | Ophthalmic | As Required |
| Paediatric Dosage (20kg) | ||||
| No data. | ||||
| Neonatal Dosage (3kg) | ||||
| No data. | ||||
Drug Interactions
None recorded.
Side Effects
Sodium Hyaluronate in overdosage may give rise to further complications which include Increased IOP (intraocular pressure).
Sodium Hyaluronate is known to cause more or less tolerable side effects which are usually transient. These include Corenal edema, Corneal decomposition, Inflammation.
Available Brands
Storage Conditions
Drug Classification
- 1.21.7 — Other ophthalmologicals